Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $36.4300 (-2.23%) ($35.6000 - $39.2800) on Thu. Dec. 3, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.18% (three month average) | RSI | 71 | Latest Price | $36.4300(-2.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1% a day on average for past five trading days. | Weekly Trend | ATRA advances 9.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) IBB(53%) ARKG(49%) IWO(48%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -2.59% in a week (0% probabilities). VIXM(-17%) TLT(-13%) UUP(-8%) UNG(-2%) SHY(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.59% (StdDev 5.18%) | Hourly BBV | 0 () | Intraday Trend | -4.2% | | | |
|
5 Day Moving Average | $38.05(-4.26%) | 10 Day Moving Average | $36.71(-0.76%) | 20 Day Moving Average | $34.62(5.23%) | To recent high | -7.9% | To recent low | 52.6% | Market Cap | $2.707b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |